Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 This is to inform the exchange that our Associate Company, Rhizen Pharmaceuticals SA ('Rhizen') has released a Press Release announcing that it has entered into an exclusive license agreement with Curon Biopharmaceutical Limited for development and commercialization of Tenalisib, a Dual PI3K Delta and Gamma Inhibitor for Oncology in Greater China. Please find enclosed herewith Rhizen's press release. Alembic Pharmaceuticals Limited through its wholly owned subsidiary holds 50% ownership in Rhizen. We request you to kindly take the same on record.
13-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of Notice of Board Meeting published in English and vernacular language (Gujarati) newspaper on 10th October, 2020 in Economic Times English Edition, Indian Express English Edition and Financial Express Gujarati Edition. We request you to kindly take the same on record.
12-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Board Meeting Intimation for Board Meeting To Consider Unaudited Financial Results For The Quarter And Half Year Ended 30Th September, 2020

 ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2020 ,inter alia, to consider and approve With reference to the captioned matter, the exchange is hereby informed that a Meeting of Board of Directors of the Company will be held on Thursday, 22nd October, 2020, inter-alia to consider and approve Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2020. Pursuant to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st October, 2020, will re-open 48 hours after the declaration of the financial results.
09-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Certificate For The Half Year Ended 30Th September, 2020

 With reference to the captioned subject, we enclose herewith Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 30th September, 2020, issued by M/s. Samdani Shah & Kabra, Practising Company Secretaries, Vadodara. We request you to kindly take the same on record.
07-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliance Certificate For The Half Year Ended 30Th September, 2020

 With reference to the captioned subject, we hereby confirm that all activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent viz. Link Intime India Private Limited, which is a SEBI approved Category-I Registrar & Transfer Agent, registered with the Securities and Exchange Board of India (SEBI Registration Number: INR000004058). We request you to kindly take the same on record.
07-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Shareholding for the Period Ended September 30, 2020

 Alembic Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here
07-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September, 2020, received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of our Company. We request you to kindly take the same on record.
07-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Statement Of Investor Complaints For The Quarter Ended September 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0330 Name of the Signatory :- Charandeep Singh SalujaDesignation :- Company Secretary and Compliance Officer
07-10-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window

 With reference to the captioned matter, this is to inform the exchange that in terms of the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will remain closed from 1st October, 2020 till 48 hours after the declaration of the unaudited financial results for the quarter and half year ended 30th September, 2020. The date of the Board Meeting for considering the unaudited financial results for the quarter and half year ended 30th September, 2020 will be intimated in due course. We request you to kindly take the same on record.
25-09-2020
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform the exchange that the share certificate of the Company has been reported as lost/misplaced and the shareholder(s) or their legal heir(s) of such lost share certificate have requested the Company for issue of duplicate share certificate. We enclose herewith a letter received from Link Intime India Private Limited, Registrar and Share Transfer Agent giving the proof of the date of receipt of aforesaid information by the Company. We request you to kindly take the same on record.
14-09-2020
Next Page
Close

Let's Open Free Demat Account